Rachel Vaknin
2022
In 2022, Rachel Vaknin earned a total compensation of $234.6K as CFO at StemCells.
Compensation breakdown
| Option Awards | $45,263 |
|---|---|
| Salary | $189,384 |
| Total | $234,647 |
Vaknin received $189.4K in salary, accounting for 81% of the total pay in 2022.
Vaknin also received $45.3K in option awards.
Rankings
In 2022, Rachel Vaknin's compensation ranked 5,252nd out of 5,692 executives tracked by ExecPay. In other words, Vaknin earned more than 7.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,252 out of 5,692 | 8th |
Division Manufacturing | 2,878 out of 3,097 | 7th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 431 out of 475 | 9th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 309 out of 340 | 9th |
Industry Surgical and Medical Instruments and Apparatus | 225 out of 246 | 9th |
Source: SEC filing on September 19, 2023.
Vaknin's colleagues
We found three more compensation records of executives who worked with Rachel Vaknin at StemCells in 2022.